Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ena-DATASET-KU-MEL-12-04-2016-11:49:00:586-275 - samples

ABSTRACT: high-throughput sequencing of methylated and hydroxymethylated DNA from tumor and non-tumor tissue of patients with high-risk prostate cancer

PROVIDER: EGAD00001002010 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Publications

Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1.

Spans Lien L Van den Broeck Thomas T Smeets Elien E Prekovic Stefan S Thienpont Bernard B Lambrechts Diether D Karnes R Jeffrey RJ Erho Nicholas N Alshalalfa Mohammed M Davicioni Elai E Helsen Christine C Gevaert Thomas T Tosco Lorenzo L Haustermans Karin K Lerut Evelyne E Joniau Steven S Claessens Frank F

Oncotarget 20160401 17

The clinical heterogeneity of prostate cancer (PCa) makes it difficult to identify those patients that could benefit from more aggressive treatments. As a contribution to a better understanding of the genomic changes in the primary tumor that are associated with the development of high-risk disease, we performed exome sequencing and copy number determination of a clinically homogeneous cohort of 47 high-risk PCas. We confirmed recurrent mutations in SPOP, PTEN and TP53 among the 850 point mutati ...[more]

PMID: 27014907

Similar Datasets

KU-MEL

Project description:Organisation EGAO00000000350

| EGAO00000000350 | EGA

High-throughput single-base resolution mapping of 2’-O-Methylated residues

Project description:High-throughput single-base resolution mapping of 2’-O-Methylated residues

| PRJNA295991 | ENA

Methanosarcina acetivorans C2A

Project description:High-throughput RNA sequencing of methanosarcina grown on methylated sulfur compounds

| PRJNA270832 | ENA

Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer

Project description:High-throughput analyses of concordant gene methylation and expression events were carried out for 91 human prostate specimens, including prostate cancer (T), matched normal adjacent to tumor (AT), and organ donor (OD). Methylated DNA in genomic DNA was immunoprecipitated with anti-methylcytidine antibodies and detected by Affymetrix human whole genome SNP 6.0 chips. Methylated genomic DNA was purified by 5-hmc antibodies and Affymetrix SNP arrays were performed according to the manufacturer's manual.

2013-08-01 | GSE45000 | GEO

DNA methylation of dnmt3a deficient Kras lung tumors and dnmt3a wt Kras lung tumors

Project description:To examine whether Dnmt3a deficiency resulted in genomic methylation changes we performed an unbiased methylome analysis. Methylated DNA isolated from three Dnmt3a deficient and two WT tumors was immunoprecipitated and subjected to high throughput sequencing (MeDIP-Seq). We observed that genes that were less expressed in Dnmt3a deficient tumors tended to have lower methylation levels in gene bodies. Examination of methylcytosine in two tumor types

2011-10-25 | E-GEOD-32484 | biostudies-arrayexpress

Integrated analyses of DNA methylation and hydroxymethylation reveal tumor suppressive roles of ECM1, ATF5 and EOMES in human hepatocellular carcinoma

Project description:The newly discovered 5-hydroxymethylcytosine (5hmC) may complicate previous observations of abnormal cytosine methylation statuses used for the identification of new tumor suppressor gene candidates relevant to human hepatocarcinogenesis. The simultaneous detection of 5mC and 5hmC will stimulate the discovery of aberrantly methylated genes with increased accuracy in human hepatocellular carcinoma (HCC). Here, we performed a newly developed single-base high-throughput sequencing approach (hydroxymethylation and methylation Sensitive Tag sequencing, HMST-seq) to synchronously measure these two modifications in HCC samples. After identifying the differentially methylated and hydroxymethylated genes in HCC, we integrated the DNA copy-number alterations as determined using array-based comparative genomic hybridization (aCGH) data with gene expression to identify genes potentially silenced by promoter hypermethylation. As a result, we report a high enrichment of genes with epigenetic aberrations in cancer signaling pathways. Six genes were selected as tumor suppressor gene (TSG) candidates, among which, ECM1, ATF5 and EOMES were confirmed to have potential anti-cancer function via siRNA experiments. To fully examine 5mC and 5hmC status in HCC, we used a newly developed single-base high-throughput sequencing approach (hydroxymethylation and methylation sensitive tag sequencing, HMST-seq) to synchronously measure these two modifications in HCC samples and their adjacent non-cancerous liver tissues (non-HCCs).

2014-09-01 | E-GEOD-54141 | biostudies-arrayexpress

Expression profiling of 275 lung cancer specimens

Project description:From ~1,700 non-small cell lung cancer specimens collected at the MD Anderson Cancer Center over the years 1997 to 2005, we selected 914 tumors with detailed clinical and pathological information. We extracted RNA and DNA from frozen tissues using histology quality control from 700 cases. RNA was examined for quality using Agilent Bioanalyzer and RNA integrity number (RIN) was obtained for all specimens. A final selection of 275 tumor specimens was based on the following criteria: 1) Select mainly adenocarcinomas (n = 183) and squamous carcinomas (n = 80); 2) Tissue material contains at least 70% tumor by section examination; 3) within the tumor section, there should be at least 30% tumor cells (as opposed to stromal cells); 4) RIN should be at least 4.0 (range 0 - 10). Various profiling experiments were then performed including mRNA expression (this study), miRNA profiling, aCGH (Agilent), Reverse-phase protein array (RPPA), mutation analysis of 20 genes (Sequenom) and MS-MALDI-TOFF analysis.

2013-07-01 | GSE41271 | GEO

Arabidopsis thaliana

Project description:High-throughput sequencing of methylated cytosine enriched by modification-dependent restriction endonuclease MspJI

| PRJNA200314 | ENA

Expression profiling of 275 lung cancer specimens

2013-07-01 | E-GEOD-41271 | biostudies-arrayexpress

Clinical study on diagnosis of colorectal cancer based on high-throughput tumor antigen polypeptides screening

Project description:Interventions: Gold Standard:Pathological diagnosis;Index test:high-throughput tumor antigen polypeptides screening Primary outcome(s): Diagnostic accuracy Study Design: Factorial

| 2704426 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data